Universal Biosensors, Inc. (UBI.AX)
AUD 0.06
(-1.61%)
AUD 0.06
(-1.61%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 30.12 Million AUD | -34.73% |
| 2022 | 46.14 Million AUD | 3.69% |
| 2021 | 44.5 Million AUD | -21.07% |
| 2020 | 56.38 Million AUD | -10.02% |
| 2019 | 62.65 Million AUD | -10.46% |
| 2018 | 69.97 Million AUD | 51.26% |
| 2017 | 46.26 Million AUD | -7.46% |
| 2016 | 49.98 Million AUD | 11.21% |
| 2015 | 44.95 Million AUD | -5.43% |
| 2014 | 47.53 Million AUD | -12.98% |
| 2013 | 54.61 Million AUD | 11.32% |
| 2012 | 49.06 Million AUD | 8.52% |
| 2011 | 45.21 Million AUD | -16.01% |
| 2010 | 53.83 Million AUD | -4.0% |
| 2009 | 56.08 Million AUD | 2.55% |
| 2008 | 54.68 Million AUD | -14.36% |
| 2007 | 63.85 Million AUD | 60.11% |
| 2006 | 39.88 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 29.11 Million AUD | -11.89% |
| 2024 Q1 | 27.89 Million AUD | -7.39% |
| 2024 Q2 | 33.03 Million AUD | 18.44% |
| 2023 Q1 | 42.22 Million AUD | -8.49% |
| 2023 Q4 | 30.12 Million AUD | -7.16% |
| 2023 FY | 30.12 Million AUD | -34.73% |
| 2023 Q2 | 37.98 Million AUD | -10.04% |
| 2023 Q3 | 32.44 Million AUD | -14.59% |
| 2022 Q2 | 65.1 Million AUD | 45.41% |
| 2022 FY | 46.14 Million AUD | 3.69% |
| 2022 Q1 | 44.77 Million AUD | 0.61% |
| 2022 Q3 | 61.71 Million AUD | -5.21% |
| 2022 Q4 | 46.14 Million AUD | -25.22% |
| 2021 FY | 44.5 Million AUD | -21.07% |
| 2021 Q4 | 44.5 Million AUD | -6.81% |
| 2021 Q1 | 52.56 Million AUD | -6.77% |
| 2021 Q2 | 50.13 Million AUD | -4.62% |
| 2021 Q3 | 47.75 Million AUD | -4.75% |
| 2020 Q4 | 56.38 Million AUD | -4.96% |
| 2020 Q1 | 65.68 Million AUD | 4.82% |
| 2020 Q2 | 61.87 Million AUD | -5.8% |
| 2020 FY | 56.38 Million AUD | -10.02% |
| 2020 Q3 | 59.32 Million AUD | -4.12% |
| 2019 Q3 | 60.82 Million AUD | -0.48% |
| 2019 FY | 62.65 Million AUD | -10.46% |
| 2019 Q2 | 61.11 Million AUD | -1.67% |
| 2019 Q1 | 62.15 Million AUD | -11.18% |
| 2019 Q4 | 62.65 Million AUD | 3.02% |
| 2018 Q4 | 69.97 Million AUD | -22.0% |
| 2018 Q1 | 48.33 Million AUD | 4.47% |
| 2018 FY | 69.97 Million AUD | 51.26% |
| 2018 Q2 | 48.29 Million AUD | -0.08% |
| 2018 Q3 | 89.71 Million AUD | 85.77% |
| 2017 Q2 | 50.69 Million AUD | 0.6% |
| 2017 Q3 | 49.21 Million AUD | -2.91% |
| 2017 Q4 | 46.26 Million AUD | -6.0% |
| 2017 FY | 46.26 Million AUD | -7.46% |
| 2017 Q1 | 50.38 Million AUD | 0.8% |
| 2016 Q1 | 45.98 Million AUD | 2.29% |
| 2016 FY | 49.98 Million AUD | 11.21% |
| 2016 Q4 | 49.98 Million AUD | 20.42% |
| 2016 Q3 | 41.51 Million AUD | -6.84% |
| 2016 Q2 | 44.56 Million AUD | -3.08% |
| 2015 Q2 | 45.59 Million AUD | -3.72% |
| 2015 Q3 | 46.48 Million AUD | 1.96% |
| 2015 Q1 | 47.35 Million AUD | -0.37% |
| 2015 Q4 | 44.95 Million AUD | -3.31% |
| 2015 FY | 44.95 Million AUD | -5.43% |
| 2014 FY | 47.53 Million AUD | -12.98% |
| 2014 Q3 | 46.64 Million AUD | -2.32% |
| 2014 Q1 | 50.74 Million AUD | -7.09% |
| 2014 Q4 | 47.53 Million AUD | 1.9% |
| 2014 Q2 | 47.75 Million AUD | -5.9% |
| 2013 Q4 | 54.61 Million AUD | 32.89% |
| 2013 Q2 | 42.15 Million AUD | -8.78% |
| 2013 Q1 | 46.21 Million AUD | -5.81% |
| 2013 FY | 54.61 Million AUD | 11.32% |
| 2013 Q3 | 41.1 Million AUD | -2.5% |
| 2012 Q4 | 49.06 Million AUD | 18.94% |
| 2012 Q3 | 41.25 Million AUD | -1.8% |
| 2012 Q2 | 42.01 Million AUD | 0.0% |
| 2012 FY | 49.06 Million AUD | 8.52% |
| 2011 Q3 | 45.35 Million AUD | 0.75% |
| 2011 Q2 | 45.02 Million AUD | 0.0% |
| 2011 Q4 | 45.21 Million AUD | -0.32% |
| 2011 FY | 45.21 Million AUD | -16.01% |
| 2010 Q4 | 53.83 Million AUD | 3.26% |
| 2010 Q3 | 52.13 Million AUD | -1.38% |
| 2010 FY | 53.83 Million AUD | -4.0% |
| 2010 Q2 | 52.86 Million AUD | 0.0% |
| 2009 Q2 | 47.19 Million AUD | 0.0% |
| 2009 FY | 56.08 Million AUD | 2.55% |
| 2009 Q4 | 56.08 Million AUD | 0.0% |
| 2008 FY | 54.68 Million AUD | -14.36% |
| 2008 Q4 | 52.5 Million AUD | 0.0% |
| 2008 Q2 | 61.18 Million AUD | 0.0% |
| 2007 Q2 | 35.11 Million AUD | 0.0% |
| 2007 FY | 63.85 Million AUD | 60.11% |
| 2007 Q4 | 55.99 Million AUD | 0.0% |
| 2006 FY | 39.88 Million AUD | 0.0% |
| 2006 Q4 | 38.09 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 74.903% |
| Adherium Limited | 9.88 Million AUD | -204.641% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 70.419% |
| Atomo Diagnostics Limited | 11.37 Million AUD | -164.701% |
| Anteris Technologies Ltd | 45.7 Million AUD | 34.093% |
| Control Bionics Limited | 9.02 Million AUD | -233.658% |
| CardieX Limited | 12.64 Million AUD | -138.11% |
| Compumedics Limited | 40.35 Million AUD | 25.367% |
| Cochlear Limited | 2.74 Billion AUD | 98.903% |
| CleanSpace Holdings Limited | 26.05 Million AUD | -15.618% |
| Cyclopharm Limited | 45.91 Million AUD | 34.399% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | -25.651% |
| Nova Eye Medical Limited | 29.88 Million AUD | -0.798% |
| HeraMED Limited | 2.95 Million AUD | -920.305% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | -147.374% |
| ImpediMed Limited | 46.98 Million AUD | 35.895% |
| InhaleRx Limited | 1.57 Million AUD | -1810.119% |
| LBT Innovations Limited | 7.93 Million AUD | -279.78% |
| Micro-X Limited | 26.89 Million AUD | -11.992% |
| Neurotech International Limited | 12.21 Million AUD | -146.618% |
| OncoSil Medical Limited | 6.71 Million AUD | -348.326% |
| PolyNovo Limited | 109.16 Million AUD | 72.409% |
| Respiri Limited | 6.19 Million AUD | -386.525% |
| SomnoMed Limited | 69.8 Million AUD | 56.851% |
| Uscom Limited | 5.13 Million AUD | -486.613% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -168.802% |